Recognition of Foreign Antigen and Foreign Major Histocompatibility Complex

Adriana Colovai; Rodica Ciubotariu; Nicole Suciu-Foca; Rajfaello Cortesini

doi:10.1128/9781555818043.ch9

Chapter 9 : Recognition of Foreign Antigen and Foreign Major Histocompatibility Complex

Authors: Adriana Colovai¹, Rodica Ciubotariu¹, Nicole Suciu-Foca¹, Rajfaello Cortesini²

VIEW AFFILIATIONS HIDE AFFILIATIONS

Affiliations: 1: Department of Pathology, College of Physicians and Surgeons of Columbia University, 630 West 168th Street, New York, NY 10032; 2: Department of Surgery, Servizio Trapianti d'Organo, Instituto di II Clinica Chirurgica, Università Degli Studi di Roma “La Sapienza”,Rome, Italy

Content Type: Monograph

Publication Year: 2001

Category: Immunology

Book DOI: 10.1128/9781555818043

Chapter DOI: 10.1128/9781555818043.ch9

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Recognition of Foreign Antigen and Foreign Major Histocompatibility Complex, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555818043/9781555811679_Chap09-1.gif /docserver/preview/fulltext/10.1128/9781555818043/9781555811679_Chap09-2.gif

Abstract:

This chapter discusses human anti-pig T-cell responses as this system is particularly relevant to clinical transplantation. T-cell recognition of foreign major histocompatibility complex (MHC) antigens has represented a challenging enigma for cellular immunologists over more than three decades. First, T-cell reactivity to nominal antigens can be detected only if the individual had been primed in vivo with the respective antigen, or after in vitro immunization by multiple antigenic stimulations. The second major difference between T-cell responses to allogeneic or xenogeneic cells and reactivity to nominal antigens resides in the lack of self-MHC restriction and processing requirements for recognition of foreign cell surface MHC antigens. Elucidation of the three-dimensional structure of class 1(11) and class II MHC (17) molecules, together with major advances in our understanding of antigen processing and presentation, had clarified considerably the molecular basis of direct T-cell recognition. The emerging picture is that both the allogeneic MHC molecule itself and the bound peptides may each independently contribute to reactivity and, furthermore, that peptide binding to MHC may induce conformational changes in the MHC molecule itself that affect recognition. Indirect recognition of xenogeneic antigens is likely to induce more powerful immune responses than human allogeneic MHC antigens, because of the larger number of foreign antigenic peptides that result from the processing of xenogeneic proteins. In conclusion, xenografts, like allografts, elicit T-cell-mediated immune responses against foreign antigens present in the graft, via the direct and indirect recognition pathways.

Citation: Colovai A, Ciubotariu R, Suciu-Foca N, Cortesini R. 2001. Recognition of Foreign Antigen and Foreign Major Histocompatibility Complex, p 175-189. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch9

Highlighted Text: Show | Hide

Full text loading...

References

/content/book/10.1128/9781555818043.chap9

1. Auchincloss, H., Jr.,, R. Lee,, S. Shea,, J. S. Markowitz,, M. J. Grusby,, and L. H. Glimcher. 1993. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc. Natl. Acad. Sci. USA 90: 3373– 3377.

2. Auchincloss, H., Jr.,, and D. H., Sachs. 1998. Xenogeneic transplantation. Annu. Rev. Immunol. 16: 433– 470.

3. Bach, F. H.,, H. Winkler,, C. Ferran,, W. W. Hancock,, and S. C. Robson. 1996. Delayed xenograft rejection. Immunol. Today 8: 379– 384.

4. Barin, F.,, M. F. McLane,, J. S. Allan,, T. H. Lee,, J. E. Groopman,, and M. Essex. 1995. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science 228: 1094– 1096.

5. Batten, P.,, M. H. Yacoub,, and M. L. Rose. 1996. Effect of human cytokines (IFN- γ, TNF- 7alpha;, IL-1 β, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes. Immunology 87: 127– 133.

6. Benichou, G.,, and E. V. Fedoseyeva. 1996. The contribution of peptides to T cell allorecognition and allograft rejection. Int. Rev. Immunol. 13: 231– 245.

7. Benichou, G.,, R. A. Takizawa,, R. T. Ho,, C. C. Killion,, C. A. Olson,, M. McMillan,, and E. E. Sercarz. 1990. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides. J. Exp. Med. 172: 1341– 1346.

8. Benichou, G.,, P. A. Takizawa,, A. C. Olson,, M. McMillan,, and E. E. Sercarz. 1992. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med. 175: 305– 308.

9. Bennett, S. R. M.,, F. R. Carbone,, F. Karamalis,, R. A. Flavell,, J. F. Miller,, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature 393: 478– 480.

10. Birmele, B.,, G. Thibault,, H. Nivet,, Y. Gruel,, P. Bardos,, and Y. Lebranchu. 1996. Human lymphocyte adhesion to xenogeneic porcine endothelial cells: modulation by human TNF- ? and involvement of NLA-4 and LFA-1. Transplant. Immunol. 4: 265– 270.

11. Bjorkman, P. J.,, M. A. Saper,, B. Samraoui,, W. S. Bennett,, J. L. Strominger,, and D. C. Wiley. 1987. Structure of the human class I histocompatibility antigen HLA-A2. Nature 329: 506– 512.

12. Bohm, W.,, R. Schirmbeck,, A. Elbe,, K. Melber,, D. Diminky,, G. Kraal,, N. van Rooijen,, Y. Barenholz,, and J. Reimann. 1995. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J. Immunol. 155: 3313– 3321.

13. Bottino, R.,, L. A. Fernandez,, C. Ricordi,, R. Lehmann,, M. F. Tsan,, R. Oliver,, and L. Inverardi. 1998. Transplantation of allogeneic islet of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 47: 316– 323.

14. Bradley, J. A. 1996. Indirect T cell recognition in allograft rejection. Int. Rev. Immunol. 13: 245– 255.

15. Bravery, C. A.,, P. Batten,, M. H. Yacoub,, and M. L. Rose. 1995. Direct recognition of SLA- and HLA-like class II antigens on porcine endothelium by human T cells results in T cell activation and release of interleukin-2. Transplantation 60: 1024– 1033.

16. Brevan, M. J. 1984. High determinant density may explain the phenomenon of alloreactivity. Immunol. Today 5: 128– 130.

17. Brown, J. H.,, T. S. Jardetzky,, J. C, Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA- DRl. Nature 364: 33– 39.

18. Butler, D. 1998. Last chance to stop and think on risk of xenotransplants. Nature 391: 320– 325.

19. Caux, C.,, C. Massacrier,, B. Vanbervliet,, B. Dubois,, C. Van Kooten,, I. Durand,, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180: 1263– 1272.

20. Cella, M.,, D. Scheidegger,, K. Palmer-Lehman,, P. Lane,, A. Lanzavecchia,, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleuken-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184: 747– 752.

21. Cen, H.,, M. C. Breinig,, R. W. Atchinson,, M. Ho,, and J. L. C. McKnight. 1991. Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4. J. Virol. 65: 976– 980.

22. Chan, D. V.,, and H. Auchincloss, Jr. 1996. Human anti-pig cell-mediated cytotoxicity in vitro involves non-T as well as T cell components. Xenotransplantation 3: 158– 165.

23. Chapman, L. E.,, T. M. Folles,, D. R. Salomon,, A. P. Patterson,, T. E. Eggerman,, and P. D. Noguchi. 1995. Xenotransplantation and xenogeneic infections. N. Engl. J. Med. 333: 1498– 1501.

24. Chitillan, H. V.,, T. M. Lauler,, K. Stenger,, S. Shea,, and H. Auchincloss, Jr. 1998. The strength of cell-mediated xenograft rejection in the mouse is due to the CD4 + indirect response. Xenotransplantation 5: 93– 98.

25. Chou, S. 1986. Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. N. Engl. J. Med. 314: 1418– 1423.

26. Ciubotariu, R.,, A. I. Colovai,, G. Pennesi,, Z. Lui,, D. Smith,, P. Berlocco,, R. Cortesini,, and N. Suciu-Foca. 1998. Specific suppression of human CD4 + T helper cell responses to pig MHC antigens by CD8 +CD28 − regulatory T cells. J. Immunol. 161: 5193– 5202.

27. Ciubotariu, R.,, Z. Liu,, A. I. Colovai,, E. Ho,, S. Ravalli,, S. Itescu,, M. A. Hardy,, R. Cortesini,, E. A. Rose,, and N. Suciu-Foca. 1998. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J. Clin. Invest. 101: 398– 405.

28. Cocchi, F.,, A. L. DeVico,, D. A. Garzino,, S. K. Arya,, R. C. Gallo,, and P. Lasso. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8 + T cells. Science 270: 1811– 1815.

29. Cooper, D. K. C.,, Y. Ye,, L. L. Rolf, Jr.,, and N. Zuhdi,. 1991. The pig as potential organ donor for man, p. 481. In D. K. C. Cooper,, E. Kemp,, K. Reemsta,, and D. J. G. White (ed.), Xenotransplantation. Springer-Verlag, Heidelberg, Germany.

30. Cozzi, E.,, and D. J. G. White. 1995. The generation of transgenic pigs as potential organ donors for humans. Nature Med. 1: 964– 966.

31. Dorling, A.,, R. Binns,, and R. I. Lechler. 1996. Cellular xenoresponses: observation of significant primary indirect human T cell anti-pig xenoresponses using co-stimulator-deficient or SLA class II-negative porcine stimulators. Xenotransplantation 3: 112– 119.

32. Emilie, D.,, M. D. Maillot,, J. F. Nicolas,, R. Fior,, and P. Galanand. 1992. Antagonistic effect of interferon-gamma on tat-induced transactivation of HIV long terminal repeat. J. Biol. Chem. 267: 20565– 20570.

33. Fangmann, J.,, R. Dalchau,, and J. W. Fabre. 1992. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J. Exp. Med. 175: 1521– 1529.

34. Fischer Lindahl, K.,, and D. B. Wilson. 1977. Histocompatibility antigen-activated cytotoxic T lymphocytes II. Estimates of frequency and specificity of precursors. J. Exp. Med. 145: 508– 522.

35. Gallimore, A.,, M. Cranage,, N. Cook,, N. Almond,, J. Bootman,, E. Rud,, P. Silvera,, M. Dennis,, T. Corcoran,, J. Stott, et al. 1995. Early suppression of SIV replication by CD8 + nef-specific cytotoxic T cells in vaccinated macaques. Nature Med. 1: 1167– 1173.

36. Goodman, D. J.,, M. A. von Albertini,, A. Shea,, C. J. Wrighton,, and F. H. Bach. 1996. Adenoviral-mediated overexpression of KBα in endothelial cells inhibits natural killer cell-mediated endothelial cell activation. Transplantation 62: 967– 972.

37. Greenstein, J. L.,, and D. H. Sachs. 1997. The use of tolerance for transplantation across xenogeneic barriers. Nature Biotechnol. 15: 235– 238.

38. Harding, C. V.,, and R. Song. 1994. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153: 4925– 4933.

39. Heber-Katz, E.,, R. H. Schwartz,, L. A. Matis,, C. Hannum,, T. Fairwell,, E. Apella,, and D. Hansburg. 1982. Contribution of antigen-presenting cell major histocompatibility complex gene products to the specificity of antigen-induced T cell activation. J. Exp. Med. 155: 1086– 1099.

40. Ildstad, S. T.,, and D. H. Sachs. 1984. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307: 168– 170.

41. Inverardi, L.,, M. Samaja,, R. Motterlini,, F. Mangili,, J. R. Bender,, and R. Pardi. 1992. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J. Immunol. 149: 1416– 1423.

42. Jiang, S.,, S. Tugulea,, G. Pennesi,, Z. Liu,, A. Mulder,, S. Lederman,, P. Harris,, R. Cortesini,, and N. Suciu-Foca. 1998. Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro. Hum. Immunol. 59: 690– 699.

43. Kirk, A. D.,, R. A. Li,, M. S. Kinch,, K. A. Abernethy,, C. Doyle,, and R. R. Bollinger. 1993. The human antiporcine cellular repertoire: in vitro studies of acquired and innate cellular responsiveness. Transplantation 55: 924– 931.

44. Kirk, A. K.,, D. M. Harland,, N. N. Armstrong,, T. A. Davis,, Y. Dong,, G. S. Gray,, X. Hong,, D. Thomas,, J. H. Fechner, Jr.,, and S. J. Knechtle. 1997. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA 194: 8789– 8794.

45. Koch, F.,, U. Stanzl,, R. Jennewein,, K. Janke,, C. Heufler,, £. Kampgen,, N. Romani,, and G. Schuler. 1996. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-10. J. Exp. Med. 184: 741– 746.

46. Korsgren, O. 1997. Acute cellular xenograft rejection. Xenotransplantation 4: 11– 19.

47. Larsen, C. P.,, D. Z. Alexander,, D. Hollenbaugh,, E. T. Elwood,, S. C. Ritchie,, A. Aruffo,, R. Hendrix,, and T. C. Pearson. 1996. CD40-gp30 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 61: 4– 9.

48. Larsen, C. P.,, E. T. Elmwood,, D. Z. Alexander,, S. C. Ritchie,, R. Hendrix,, D. Tucker,, C. Burden,, H. R. Cho,, A. Aruffo,, D. Hollenbaugh,, P. S. Linsley,, K. J. Winn,, and T. C. Pearson. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381: 434– 438.

49. Lechler, R. I.,, and J. R. Batchelor. 1982. Restoration of immunogenicity to passenger cell depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155: 31– 41.

50. Lee, R. S.,, M. J. Grusby,, L. H. Glimcher,, H. J. Winn,, and H. Auchincloss, Jr. 1994. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J. Exp. Med. 179: 865– 872.

51. Lehmann, P. V.,, T. Forsthuber,, A. Miller,, and E. E. Sercarz. 1992. Spreading of T cell autoimmunity to cryptic determinants of autoantigen. Nature 358: 155– 157.

52. Levisetti, M. G.,, P. A. Padrid,, G. L. Szat,, N. Mittal,, S. M. Meehan,, C. L. Wardrip,, G. S. Gray,, D. S. Bruce,, J. R. Thistlewaite, Jr.,, and J. A. Bluestone. 1997. Immunosuppressive effects of human CTLA4-Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J. Immunol. 159: 5187– 5191.

53. Lipham, W. J.,, T. M. Redmond,, H. Takahashi,, J. A. Berzofsky,, B. Wiggert,, G. J. Chader,, and I. Gery. 1991. Recognition of peptides that are immunopathogenic but cryptic. Mechanisms that allow lymphocytes sensitized against cryptic peptides to initiate pathogenic autoimmune process. J. Immunol. 146: 3757– 3762.

54. Liu, Z.,, A. I. Colovai,, S. Tugulea,, E. F. Reed,, P. E. Fisher,, D. Mancini,, E. A. Rose,, R. Cortesini,, R. E. Michler,, and N. Suciu-Foca. 1996. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J. Clin. Invest. 98: 1150– 1157.

55. Liu, Z.,, P. E. Harris,, A. I. Colovai,, E. F. Reed,, A. Maffei,, and N. Suciu-Foca. 1996. Indirect recognition of donor MHC-class II antigens in human transplantation. Clin. Immunol. Immunopathol. 78: 228– 235.

56. Liu, Z.,, Y. K. Sun,, Y. P. Xi,, B. Hong,, P. E. Harris,, E. Reed,, and N. Suciu-Foca. 1993. Limited usage of TCR V/3 genes by allopeptide specific T cells. J. Immunol. 150: 3180– 3186.

57. Liu, Z.,, S. Tugulea,, R. Cortesini,, and N. Suciu-Foca. 1998. Specific suppression of T helper alloreactivity by allo-MHC-class I restricted CD8 + CD28 −T cells. Int. Immunol. 10: 101– 109.

58. Lo, D.,, L. C. Burkly,, R. A. Flavell,, R. D. Palmiter,, and R. L. Brinster. 1989. Tolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells. J. Exp. Med. 170: 87– 104.

59. Lombardi, G.,, S. Sidhu,, J. R. Batchelor,, and R. I. Lechler. 1989. Allorecognition of DR1 by T cells from a DR4/DRwl3 responder mimics self-restricted recognition of endogenous peptides. Proc. Natl. Acad. Sci. USA 86: 4190– 4194.

60. Mackewicz, C. E.,, L. C. Yang,, J. D. Lifson,, and J. A. Levy. 1994. Non-cytotoxic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet 344: 1671– 1674.

61. Maher, S. E.,, K. Karmann,, W. Min,, C. C. W. Hughes,, J. S. Pober,, and A. L. M. Bothwell. 1996. Porcine endothelial CD86 is a major costimulator of xenogeneic human T cells. J. Immunol. 157: 3838– 3844.

62. Mandel, T. E.,, J. Kovarik,, M. Koulmanda,, and H. M. Georgiou. 1997. Cellular rejection of fetal pancreas grafts: differences between allo- and xenografts rejection. Xenotransplantation 4: 2– 10.

63. Markmann, J. F.,, L. Campos,, A. Bhandoola,, J. I. Kim,, N. M. Desai,, H. Bassiri,, B. R. Claytor,, and C. F. Barker. 1994. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts. Surgery 116: 242– 248.

64. Matzinger, P.,, and M. J. Brevan. 1977. Why do so many lymphocytes respond to major histocompatibility complex antigens? Cell Immunol. 29: 1– 5.

65. McMichael, A. J.,, F. M. Gotch,, G. R. Noble,, and P. A. S. Beare. 1983. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 309: 13– 17.

66. Michaels, M. G. 1997. Infectious concerns of cross-species transplantation: xenozoonoses. World J. Surg. 21: 968– 974.

67. Moses, R. D.,, R. N. I. Pierson,, H. J. Winn,, and H. J. Auchincloss. 1990. Xenogeneic proliferation and lymphokine production are dependent on CD4 + helper T cells and self-antigen-presenting cells in the mouse. J. Exp. Med. 172: 567– 575.

68. Murray, A. G.,, M. M. Khodadoust,, J. S. Pober,, and A. L. M. Bothwell. 1994. Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1: 57– 63.

69. Nuchtern, J. G.,, W. E. Biddison,, and R. D. Klausner. 1990. Class II molecules can use the endogenous pathway of antigen presentation. Nature 343: 74– 76.

70. Patience, C.,, Y. Takeuchi,, and R. A. Weiss. 1997. Infection of human cells by an endogenous retrovirus of pigs. Nature Med. 3: 282– 286.

71. Pearson, T. C.,, D. Z. Alexander,, K. J. Winn,, P. S. Linsley,, R. P. Lowry,, and C. P. Larsen. 1994. Transplantation tolerance induced by CTLA4-Ig. Transplantation 57: 1701– 1706.

72. Peguet-Navarro, J.,, C. Dalbiez-Gauthier,, F. M. Rattis,, C. Van Kooten,, J. Banchereau,, and D. Schrru'tt. 1995. Functional expression of CD40 antigen on human epidermal Langerhans cells. J. Immunol. 155: 4241– 4247.

73. Pereira, B. J. G.,, E. L. Milford,, R. L. Kirkman,, and A. S. Levey. 1991. Transmission of hepatitis C virus by organ transplantation. N. Engl. J. Med. 325: 454– 460.

74. Pierson, R. N.,, H. J. Winn,, P. S. Russell,, and H. Auchincloss, Jr. 1989. Xenogeneic skin graft rejection is especially dependent on CD4 + T cells. J. Exp. Med. 170: 991– 996.

75. Platt, J. L. 1998. New directions for organ transplantation. Nature 392: 11– 17.

76. Platt, J. L.,, B. J. Lindman,, R. L. Geller,, H. J. Noreen,, J. L. Swanson,, A. P. Dalmasso,, and F. H. Bach. 1991. The role of natural antibodies in the activation of xenogeneic endothelial cells. Transplantation 52: 1037– 1043.

77. Purcell, D. F.,, C. M. Broscius,, E. F. Vanin,, C. E. Buckler,, A. W. Nienhuis,, and M. A. Martin. 1996. An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer. J. Virol. 70: 887– 897.

78. Putney, S. D.,, T. J. Matthews,, W. G. Robey,, D. L. Lynn,, M. R. Guroff,, W. T. Mueller,, A. J. Langlois,, J. Ghrayeb,, S. R. Petteway,, K. J. Weinhold, et al. 1986. HTLV-HI/LAV-neutralizing antibodies to an E. coli'-produced fragment of the virus envelope. Science 234: 1392– 1395.

79. Renna Molajoni, E.,, P. Cinti,, A. Orlandini,, J. Molajoni,, S. Tugulea,, E. Ho,, Z. Liu,, N. Suciu-Foca,, and R. Cortesini. 1997. Mechanism of liver allograft rejection: the indirect recognition pathway. Hum. Immunol. 53: 57– 63.

80. Ricordi, C.,, S. T. Ildstad,, A. J. Demetris,, A. Y. Abou El-Ezz,, N. Murase,, and T. E. Styarzl. 1992. Donor dendritic cells repopulation in recipients after rat-to-mouse bone-marrow transplantation. Lancet 339: 1610– 1611.

81. Ridge, J. P.,, F. DiRosa,, and P. Matzinger. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4 + T-helper and a T-killer cell. Nature 393: 474– 478.

82. Roetzchke, O.,, K. Falk,, S. Faath,, and H. G. Rammensee. 1991. On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 174: 1059– 1071.

83. Rosenberg, A. S.,, T. Mizuochi,, S. O. Sharrow,, and A. Singer. 1987. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J. Exp. Med. 165: 1296– 1315.

84. Rother, R. P.,, W. L. Fodor,, J. P. Springhorn,, C. W. Birks,, E. Setter,, M. S. Sandrin,, S. P. Squinto,, and S. A. Rollins. 1995. A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. J. Exp. Med. 182: 1345– 1355.

85. Rowland-Jones, S.,, R. Ian,, and A. McMichael. 1997. Role of cellular immunity in protection against HIV infection. Adv. Immunol. 65: 277– 346.

86. Sachs, D. H. 1994. The pig as potential xenograft donor. Vet. Immunol. Immunopathol. 43: 185– 191.

87. Sandrin, M. S.,, H. A. Vaughan,, and I. F. C. McKenzie. 1994. Identification of Gal (α 1.3) Gal as the major epitope for pig-to-human vascularized xenografts. Transplant. Res. 8: 134– 149.

88. Satake, M.,, N. Kawagishi,, and E. Moller. 1996. Direct activation of human responder T cells by porcine stimulator cells leads to T cell proliferation and cytotoxic T cell development. Xenotransplantation 3: 198– 206.

89. Sawyer, G.,, R. Dalchau,, and J. Fabre. 1993. Indirect T cell allorecognition: a cyclosporin A resistant pathway for T cell help for antibody production to donor MHC antigens. Transplant. Immunol. 1: 77– 81.

90. Schoenberger, S. P.,, R. E. M. Toes,, E. I. H. van der Voort,, R. Offringa,, and C. J. M. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480– 483.

91. Seebach, J. D.,, C. Comrack,, S. Germana,, C. LeGuern,, D. H. Sachs,, and H. DerSimonian. 1997. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. J. Immunol. 159: 3655– 3661.

92. Shishido, S.,, B. Naziruddin,, T. Howard,, and T. Mohanakumar. 1997. Recognition of porcine major histocompatibility complex class I antigens by human CD8 + cytolytic T cell clones. Transplantation 64: 340– 346.

93. Steimer, K. S.,, C. J. Scendella,, P. V. Skiles,, and N. L. Haigwood. 1991. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gpl20. Science 254: 105– 108.

94. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271– 296.

95. Stock, P. G.,, N. L. Ascher,, S. Chen,, J. Field,, F. H. Bach,, and D. E. Sutherland. 1991. Evidence for direct and indirect pathways in the generation of the alloimmune response against pancreatic islets. Transplantation 52: 704– 709.

96. Suciu-Foca, N.,, E. Reed,, C. Marboe,, Y. P. Xi,, S. Y. Kai,, E. Ho,, E. Rose,, K. Reemtsma,, and D. W. King. 1991. Role of anti-HLA antibodies in heart transplantation. Transplantation 51: 716– 724.

97. Takahashi, T.,, S. Saadi,, and J. L. Platt. 1997. Recent advances in the immunology of xenotransplantation. Immunol. Res. 16: 273– 297.

98. Thompson, S. C.,, and T. E. Mandel. 1990. Fetal pig pancreas: preparation and assessment of tissue for transplantation, its in vivo development and function in athymic (nude) mice. Transplantation 49: 571– 581.

99. Tran, H. M.,, P. W. Nickerson,, A. C. Restifo,, M. A. Ivis-Woodward,, A. Patel,, R. D. Allen,, T. B. Strom,, and P. J. O'Connell. 1997. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Ig treatment. J. Immunol. 159: 2232– 2239.

100. Vella, J. P.,, M. Spadafora-Ferreira,, B. Murphy,, S. I. Alexander,, W. Harmon,, C. B. Carpenter,, and M. H. Sayegh. 1997. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 64: 795– 800.

101. Von Willebrand, E.,, E. Pettersson,, J. Ahonen and, P. Hayry. 1986. CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 42: 364– 367.

102. Weber, D. A.,, N. K. Terrell,, J. Zhang, et al. 1991. Requirement for peptide in alloreactive CD4 + T cell recognition of class II MHC molecules. J. Immunol. 154: 5153– 5164.

103. Xiao, E.,, A. S. Chong,, P. Foster,, H. Sankary,, L. McChesney,, G. Koukoulis,, J. Yang,, D. Frieders,, and J. W. Williams. 1994. Leflunomide controls rejection in hamster to rat cardiac xenografts. Transplantation 58: 828– 834.

104. Yamada, K.,, D. H. Sachs,, and H. DerSimonian. 1995. Human anti-porcine xenogeneic T cell response: evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J. Immunol. 155: 5249– 5256.

105. Yamada, K.,, J. D. Seebach,, H. DerSimonian,, and D. H. Sachs. 1996. Human anti-pig T-cell mediated cytotoxicity. Xenotransplantation 3: 179– 187.

106. Zinkernagel, R. M. 1996. Immunology taught by viruses. Science 271: 173– 178.

Tables

Recognition of Foreign Antigen and Foreign Major Histocompatibility Complex

[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818043.chap9-1,webId=/content/author/10.1128/9781555818043.chap9-1,properties={foaf_givenname=Adriana, foaf_name=Adriana Colovai, foaf_surname=Colovai, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818043.chap9-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818043.chap9-2,webId=/content/author/10.1128/9781555818043.chap9-2,properties={foaf_givenname=Rodica, foaf_name=Rodica Ciubotariu, foaf_surname=Ciubotariu, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818043.chap9-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818043.chap9-3,webId=/content/author/10.1128/9781555818043.chap9-3,properties={foaf_givenname=Nicole, foaf_name=Nicole Suciu-Foca, foaf_surname=Suciu-Foca, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818043.chap9-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818043.chap9-4,webId=/content/author/10.1128/9781555818043.chap9-4,properties={foaf_givenname=Rajfaello, foaf_name=Rajfaello Cortesini, foaf_surname=Cortesini, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818043.chap9-aff2]]}]]

/content/10.1128/9781555818043.chap9.tab9-1

Table 1

Characteristics of human anti-pig suppressor cells ( 37 ) a

10.1128/9781555818043/tab9-1_thmb.gif

10.1128/9781555818043/tab9-1.gif

Table 1

Characteristics of human anti-pig suppressor cells ( 37 ) a